Clobazam and Exidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobazam (clobazam) and Exidine (chlorhexidine gluconate). Common drug interactions include diarrhoea among females and blood alkaline phosphatase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Clobazam and Exidine. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Exidine?

Exidine has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 17,299 Exidine users. Check the latest studies of Exidine.



On Jul, 15, 2026

36 people who take Clobazam and Exidine together, and have interactions are studied.

Clobazam and Exidine drug interactions.

What are the common drug interactions of Clobazam and Exidine, by gender? *:

female:

  1. Diarrhoea
  2. Hypokalaemia (low potassium)
  3. Presyncope
  4. White blood cell count decreased
  5. Cerebellar haemorrhage (bleeding in cerebeller)
  6. Cerebrospinal fluid leakage
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Disturbance in attention
  9. Headache (pain in head)
  10. Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)

male:

  1. Blood alkaline phosphatase increased
  2. Blood lactate dehydrogenase increased
  3. Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
  4. Oropharyngeal pain
  5. Otitis media acute (rapid inflammation of the middle ear)
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Splenomegaly (enlargement of spleen)
  8. Cardiac arrest
  9. Device failure
  10. Aggression

What are the common drug interactions of Clobazam and Exidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cerebellar haemorrhage (bleeding in cerebeller)
  2. Cerebrospinal fluid leakage
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Disturbance in attention
  5. Headache (pain in head)
  6. Hydrocephalus (water on the brain)

10-19:

  1. Blood alkaline phosphatase increased
  2. Blood lactate dehydrogenase increased
  3. Blood uric acid increased
  4. C-reactive protein increased
  5. Diarrhoea haemorrhagic (bloody diarrhoea)
  6. Ear infection
  7. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  8. Iron deficiency
  9. Lymphadenitis (inflammation or enlargement of a lymph node)
  10. Lymphoma (cancer that begins in immune system cells)

20-29:

n/a

30-39:

  1. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  2. Skin fissures (a crack in the skin)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Cardiac arrest
  5. Device failure
  6. Diarrhoea
  7. Hypokalaemia (low potassium)
  8. Presyncope
  9. White blood cell count decreased
  10. Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)

40-49:

  1. Aggression
  2. Hospitalisation
  3. Irritability
  4. Personality change

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 20 people, 55.56%
  2. Breast Cancer Metastatic: 16 people, 44.44%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 13 people, 36.11%
  4. Nausea (feeling of having an urge to vomit): 13 people, 36.11%
  5. Stress And Anxiety: 11 people, 30.56%
  6. Pulmonary Embolism (blockage of the main artery of the lung): 11 people, 30.56%
  7. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 9 people, 25.00%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 25.00%
  9. Confusional State: 8 people, 22.22%
  10. Otitis Media (inflammation of the middle ear): 8 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and Exidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clobazam and Exidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clobazam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clobazam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clobazam and chlorhexidine gluconate (the active ingredients of Clobazam and Exidine, respectively), and Clobazam and Exidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: